14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Doppler‐Derived Renal Venous Stasis Index in the Prognosis of Right Heart Failure

      research-article
      , MD 1 , 2 , 3 , , , MD 1 , , MD 3 , , MD 1 , , MD 2 , 4 , , MD 2 , 4 , , PhD 4 , , PhD 2 , 4 , , PhD 5 , 6 , , MD 7 , , MD 2 , 4 , , MD 1 , 2 , 4 , 8 , , MD, MPH 11 , , PhD 2 , 4 , 9 , , MD 2 , 4 , 10
      Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
      John Wiley and Sons Inc.
      cardiorenal syndromes, intrarenal venous flow patterns, pulmonary hypertension, renal Doppler ultrasonography, venous congestion, Heart Failure, Cardiorenal Syndrome

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Persistent congestion with deteriorating renal function is an important cause of adverse outcomes in heart failure. We aimed to characterize new approaches to evaluate renal congestion using Doppler ultrasonography.

          Methods and Results

          We enrolled 205 patients with suspected or prediagnosed pulmonary hypertension ( PH) undergoing right heart catheterization. Patients underwent renal Doppler ultrasonography and assessment of invasive cardiopulmonary hemodynamics, echocardiography, renal function, intra‐abdominal pressure, and neurohormones and hydration status. Four spectral Doppler intrarenal venous flow patterns and a novel renal venous stasis index ( RVSI) were defined. We evaluated PH‐related morbidity using the Cox proportional hazards model for the composite end point of PH progression (hospitalization for worsening PH, lung transplantation, or PH‐specific therapy escalation) and all‐cause mortality for 1‐year after discharge. The prognostic utility of RVSI and intrarenal venous flow patterns was compared using receiver operating characteristic curves. RVSI increased in a graded fashion across increasing severity of intrarenal venous flow patterns ( P<0.0001) and was significantly associated with right heart and renal function, intra‐abdominal pressure, and neurohormonal and hydration status. During follow‐up, the morbidity/mortality end point occurred in 91 patients and was independently predicted by RVSI ( RVSI in the third tertile versus referent: hazard ratio: 4.72 [95% CI, 2.10–10.59; P<0.0001]). Receiver operating characteristic curves suggested superiority of RVSI to individual intrarenal venous flow patterns in predicting outcome (areas under the curve: 0.789 and 0.761, respectively; P=0.038).

          Conclusions

          We propose RVSI as a conceptually new and integrative Doppler index of renal congestion. RVSI provides additional prognostic information to stratify PH for the propensity to develop right heart failure.

          Clinical Trial Registration

          URL: https://www.clinicaltrials.gov/. Unique identifier: NCT03039959.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: not found

          The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

          Heart failure is a global pandemic affecting an estimated 26 million people worldwide and resulting in more than 1 million hospitalizations annually in both the United States and Europe. Although the outcomes for ambulatory HF patients with a reduced ejection fraction (EF) have improved with the discovery of multiple evidence-based drug and device therapies, hospitalized heart failure (HHF) patients continue to experience unacceptably high post-discharge mortality and readmission rates that have not changed in the last 2 decades. In addition, the proportion of HHF patients classified as having a preserved EF continues to grow and may overtake HF with a reduced EF in the near future. However, the prognosis for HF with a preserved EF is similar and there are currently no available disease-modifying therapies. HHF registries have significantly improved our understanding of this clinical entity and remain an important source of data shaping both public policy and research efforts. The authors review global HHF registries to describe the patient characteristics, management, outcomes and their predictors, quality improvement initiatives, regional differences, and limitations of the available data. Moreover, based on the lessons learned, they also propose a roadmap for the design and conduct of future HHF registries. Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.

            Results of previous studies support the hypothesis that implantable haemodynamic monitoring systems might reduce rates of hospitalisation in patients with heart failure. We undertook a single-blind trial to assess this approach. Patients with New York Heart Association (NYHA) class III heart failure, irrespective of the left ventricular ejection fraction, and a previous hospital admission for heart failure were enrolled in 64 centres in the USA. They were randomly assigned by use of a centralised electronic system to management with a wireless implantable haemodynamic monitoring (W-IHM) system (treatment group) or to a control group for at least 6 months. Only patients were masked to their assignment group. In the treatment group, clinicians used daily measurement of pulmonary artery pressures in addition to standard of care versus standard of care alone in the control group. The primary efficacy endpoint was the rate of heart-failure-related hospitalisations at 6 months. The safety endpoints assessed at 6 months were freedom from device-related or system-related complications (DSRC) and freedom from pressure-sensor failures. All analyses were by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00531661. In 6 months, 83 heart-failure-related hospitalisations were reported in the treatment group (n=270) compared with 120 in the control group (n=280; rate 0·31 vs 0·44, hazard ratio [HR] 0·70, 95% CI 0·60-0·84, p<0·0001). During the entire follow-up (mean 15 months [SD 7]), the treatment group had a 39% reduction in heart-failure-related hospitalisation compared with the control group (153 vs 253, HR 0·64, 95% CI 0·55-0·75; p<0·0001). Eight patients had DSRC and overall freedom from DSRC was 98·6% (97·3-99·4) compared with a prespecified performance criterion of 80% (p<0·0001); and overall freedom from pressure-sensor failures was 100% (99·3-100·0). Our results are consistent with, and extend, previous findings by definitively showing a significant and large reduction in hospitalisation for patients with NYHA class III heart failure who were managed with a wireless implantable haemodynamic monitoring system. The addition of information about pulmonary artery pressure to clinical signs and symptoms allows for improved heart failure management. CardioMEMS. Copyright © 2011 Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.

              To determine whether venous congestion, rather than impairment of cardiac output, is primarily associated with the development of worsening renal function (WRF) in patients with advanced decompensated heart failure (ADHF). Reduced cardiac output is traditionally believed to be the main determinant of WRF in patients with ADHF. A total of 145 consecutive patients admitted with ADHF treated with intensive medical therapy guided by pulmonary artery catheter were studied. We defined WRF as an increase of serum creatinine >/=0.3 mg/dl during hospitalization. In the study cohort (age 57 +/- 14 years, cardiac index 1.9 +/- 0.6 l/min/m(2), left ventricular ejection fraction 20 +/- 8%, serum creatinine 1.7 +/- 0.9 mg/dl), 58 patients (40%) developed WRF. Patients who developed WRF had a greater central venous pressure (CVP) on admission (18 +/- 7 mm Hg vs. 12 +/- 6 mm Hg, p < 0.001) and after intensive medical therapy (11 +/- 8 mm Hg vs. 8 +/- 5 mm Hg, p = 0.04). The development of WRF occurred less frequently in patients who achieved a CVP <8 mm Hg (p = 0.01). Furthermore, the ability of CVP to stratify risk for development of WRF was apparent across the spectrum of systemic blood pressure, pulmonary capillary wedge pressure, cardiac index, and estimated glomerular filtration rates. Venous congestion is the most important hemodynamic factor driving WRF in decompensated patients with advanced heart failure.
                Bookmark

                Author and article information

                Contributors
                faeq.husain-syed@innere.med.uni-giessen.de
                Journal
                J Am Heart Assoc
                J Am Heart Assoc
                10.1002/(ISSN)2047-9980
                JAH3
                ahaoa
                Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
                John Wiley and Sons Inc. (Hoboken )
                2047-9980
                19 October 2019
                05 November 2019
                : 8
                : 21 ( doiID: 10.1002/jah3.v8.21 )
                : e013584
                Affiliations
                [ 1 ] Division of Nephrology Department of Internal Medicine II University Hospital Giessen and Marburg Giessen Germany
                [ 2 ] Division of Pulmonology and Critical Care Medicine Department of Internal Medicine II University Hospital Giessen and Marburg Giessen Germany
                [ 3 ] International Renal Research Institute of Vicenza Department of Nephrology, Dialysis and Transplantation San Bortolo Hospital Vicenza Italy
                [ 4 ] Member of the German Centre for Lung Research (DZL) Universities of Giessen and Marburg Lung Centre (UGMLC) Giessen Germany
                [ 5 ] Department of Public Health Erasmus MC Rotterdam, The Netherlands
                [ 6 ] Department of Biomedical Data Sciences Medical Statistics and Medical Decision Making Leiden University Medical Center Leiden The Netherlands
                [ 7 ] Department of Internal Medicine I Division of Cardiology and Angiology University Hospital Giessen and Marburg Giessen Germany
                [ 8 ] Max Planck Institute for Heart and Lung Research Bad Nauheim Germany
                [ 9 ] Department of Epidemiology Erasmus MC Rotterdam The Netherlands
                [ 10 ] Department of Pulmonology Kerckhoff‐Klinik Nauheim Germany
                [ 11 ] Baylor Heart and Vascular Institute Baylor University Medical Center at Dallas TX
                Author notes
                [*] [* ] Correspondence to: Faeq Husain‐Syed, MD, University Hospital Giessen and Marburg, Department of Internal Medicine II, Division of Nephrology, Pulmonology and Critical Care Medicine, Klinikstrasse 33, 35392 Giessen, Germany. E‐mail: faeq.husain-syed@ 123456innere.med.uni-giessen.de
                [†]

                Dr Gall and Dr Ghofrani are co–last authors.

                Article
                JAH34507
                10.1161/JAHA.119.013584
                6898799
                31630601
                3b18b0af-7b6f-467e-a911-12a69f128b15
                © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 13 June 2019
                : 12 September 2019
                Page count
                Figures: 6, Tables: 2, Pages: 15, Words: 10479
                Funding
                Funded by: German Research Foundation
                Categories
                Original Research
                Original Research
                Heart Failure
                Custom metadata
                2.0
                jah34507
                5 November 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.7.1 mode:remove_FC converted:12.11.2019

                Cardiovascular Medicine
                cardiorenal syndromes,intrarenal venous flow patterns,pulmonary hypertension,renal doppler ultrasonography,venous congestion,heart failure,cardiorenal syndrome

                Comments

                Comment on this article